Literature DB >> 20660789

Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells.

Jens Stanelle1, Claudia Döring, Martin-Leo Hansmann, Ralf Küppers.   

Abstract

The transcription factor network in Hodgkin lymphoma (HL) represents a unique composition of proteins found in no other hematopoietic cell. Among these factors, an aberrant expression of the T-cell transcription factor GATA3 is observed in B cell-derived Hodgkin and Reed/Sternberg (HRS) tumor cells. Herein, we elucidate the regulation and function of this factor in HL. We demonstrate binding of NFκB and Notch-1, 2 factors with deregulated activity in HL to GATA3 promoter elements. Interference with NFκB and Notch-1 activity led to decreased GATA3 expression, indicating a dependency of deregulated GATA3 expression on these transcription factors. Down-regulation of GATA3 in HL cell lines demonstrated its role in the regulation of IL-5, IL-13, STAT4, and other genes. A correlation between GATA3 and IL-13 expression was confirmed for HRS cells in HL tissues. Thus, GATA3 shapes the cytokine expression and signaling that is typical of HL. Conclusively, aberrant GATA3 expression in HRS cells is stimulated by the deregulated constitutive activity of NFκB and Notch-1, indicating a complex network of deregulated transcription factors in these cells. GATA3 activity significantly contributes to the typical cytokine secretion of and signaling in HRS cells, which presumably plays an essential role in HL pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660789     DOI: 10.1182/blood-2010-01-265827

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

Review 1.  Hodgkin lymphoma.

Authors:  Ralf Küppers; Andreas Engert; Martin-Leo Hansmann
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

2.  Repeat-element driven activation of proto-oncogenes in human malignancies.

Authors:  Björn Lamprecht; Constanze Bonifer; Stephan Mathas
Journal:  Cell Cycle       Date:  2010-11-19       Impact factor: 4.534

3.  Utility of LRF/Pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma.

Authors:  Olga Bohn; Takahiro Maeda; Alexander Filatov; Andrea Lunardi; Pier Paolo Pandolfi; Julie Teruya-Feldstein
Journal:  Int J Surg Pathol       Date:  2013-12-10       Impact factor: 1.271

4.  Lineage-affiliated transcription factors bind the Gata3 Tce1 enhancer to mediate lineage-specific programs.

Authors:  Sakie Ohmura; Seiya Mizuno; Hisashi Oishi; Chia-Jui Ku; Mary Hermann; Tomonori Hosoya; Satoru Takahashi; James Douglas Engel
Journal:  J Clin Invest       Date:  2016-01-25       Impact factor: 14.808

5.  Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma.

Authors:  Stephan Kreher; M Amine Bouhlel; Pierre Cauchy; Björn Lamprecht; Shuang Li; Michael Grau; Franziska Hummel; Karl Köchert; Ioannis Anagnostopoulos; Korinna Jöhrens; Michael Hummel; John Hiscott; Sören-Sebastian Wenzel; Peter Lenz; Markus Schneider; Ralf Küppers; Claus Scheidereit; Maciej Giefing; Reiner Siebert; Klaus Rajewsky; Georg Lenz; Peter N Cockerill; Martin Janz; Bernd Dörken; Constanze Bonifer; Stephan Mathas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-06       Impact factor: 11.205

6.  Fbw7 targets GATA3 through cyclin-dependent kinase 2-dependent proteolysis and contributes to regulation of T-cell development.

Authors:  Kyoko Kitagawa; Kiyoshi Shibata; Akinobu Matsumoto; Masaki Matsumoto; Tatsuya Ohhata; Keiichi I Nakayama; Hiroyuki Niida; Masatoshi Kitagawa
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

7.  Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed-Sternberg cells.

Authors:  Benjamin Rengstl; Sebastian Newrzela; Tim Heinrich; Christian Weiser; Frederic B Thalheimer; Frederike Schmid; Kathrin Warner; Sylvia Hartmann; Timm Schroeder; Ralf Küppers; Michael A Rieger; Martin-Leo Hansmann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-03       Impact factor: 11.205

8.  Genome-wide association study implicates immune dysfunction in the development of Hodgkin lymphoma.

Authors:  Amit Sud; Hauke Thomsen; Giulia Orlando; Asta Försti; Philip J Law; Peter Broderick; Rosie Cooke; Fadi Hariri; Tomi Pastinen; Douglas F Easton; Paul D P Pharoah; Alison M Dunning; Julian Peto; Federico Canzian; Rosalind Eeles; ZSofia Kote-Jarai; Kenneth Muir; Nora Pashayan; Daniele Campa; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Elke Pogge von Strandmann; Anthony J Swerdlow; Andreas Engert; Nick Orr; Kari Hemminki; Richard S Houlston
Journal:  Blood       Date:  2018-09-07       Impact factor: 22.113

9.  Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.

Authors:  Kevin Y Urayama; Ruth F Jarrett; Henrik Hjalgrim; Arjan Diepstra; Yoichiro Kamatani; Amelie Chabrier; Valerie Gaborieau; Anne Boland; Alexandra Nieters; Nikolaus Becker; Lenka Foretova; Yolanda Benavente; Marc Maynadié; Anthony Staines; Lesley Shield; Annette Lake; Dorothy Montgomery; Malcolm Taylor; Karin Ekström Smedby; Rose-Marie Amini; Hans-Olov Adami; Bengt Glimelius; Bjarke Feenstra; Ilja M Nolte; Lydia Visser; Gustaaf W van Imhoff; Tracy Lightfoot; Pierluigi Cocco; Lambertus Kiemeney; Sita H Vermeulen; Ivana Holcatova; Lars Vatten; Gary J Macfarlane; Peter Thomson; David I Conway; Simone Benhamou; Antonio Agudo; Claire M Healy; Kim Overvad; Anne Tjønneland; Beatrice Melin; Federico Canzian; Kay-Tee Khaw; Ruth C Travis; Petra H M Peeters; Carlos A González; José Ramón Quirós; María-José Sánchez; José María Huerta; Eva Ardanaz; Miren Dorronsoro; Françoise Clavel-Chapelon; H Bas Bueno-de-Mesquita; Elio Riboli; Eve Roman; Paolo Boffetta; Silvia de Sanjosé; Diana Zelenika; Mads Melbye; Anke van den Berg; Mark Lathrop; Paul Brennan; James D McKay
Journal:  J Natl Cancer Inst       Date:  2012-01-27       Impact factor: 13.506

10.  Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation.

Authors:  Hongbo Yang; Hui Zhang; Yu Luan; Tingting Liu; Wentao Yang; Kathryn G Roberts; Mao-Xiang Qian; Bo Zhang; Wenjian Yang; Virginia Perez-Andreu; Jie Xu; Sriranga Iyyanki; Da Kuang; Lena A Stasiak; Shalini C Reshmi; Julie Gastier-Foster; Colton Smith; Ching-Hon Pui; William E Evans; Stephen P Hunger; Leonidas C Platanias; Mary V Relling; Charles G Mullighan; Mignon L Loh; Feng Yue; Jun J Yang
Journal:  Nat Genet       Date:  2022-02-03       Impact factor: 41.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.